A study showed that the inhibition of TGF-β increases the proliferation and matrix metallopeptidase 9 (MMP-9) expression of tumor-associated fibroblasts (TAF), which negatively regulate PD-L1 expression on the surface of tumor cells and reduce anti-PD-1 efficacy (31). This evidence concerns the gene TGFB1 and neoplasm.